Document is current

Article History

Received: 11 October 2023

Accepted: 1 October 2024

First Online: 16 October 2024

Declarations

:

: CK serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). TL serves as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), CERUS Endovascular (Fremont, CA, USA), Phenox (Bochum, Germany), Stryker (Kalamazoo, MI, USA), and Medtronic (Dublin, Ireland). DZ is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany). FD serves as consultant/ proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), Balt (Irvine, CA, USA), Cerenovus/Johnson&Johnson (Irvine, CA, USA); received speakers honoraria from Cerenovus/Johnson&Johnson (Irvine, CA, USA), Acandis (Pforzheim, Germany), Asahi (Tokyo, Japan), Q`Apel (Fremont, CA, USA), Penumbra (Alameda, CA, USA), Medtronic (Dublin, Ireland), Stryker (Kalamazoo, MI, USA); received scientific grants from Cerenovus/Johnson&Johnson (Irvine, CA, USA). The other authors declare that they have no competing interests.

: For this type of study formal consent is not required.